IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2018-06-01. The firm has sold all of its assets. The company is not engaged in any business operations.
Follow-Up Questions
IMV Inc (IMVIF) 的本益比是多少？
IMV Inc 的本益比是 0
IMV Inc 的 CEO 是誰？
Mr. Andrew Hall 是 IMV Inc 的 Chief Executive Officer，自 2020 加入公司。
